An Introduction to Head & Neck Radiotherapy.
|
|
- Sydney Moris Jones
- 6 years ago
- Views:
Transcription
1 An Introduction to Head & Neck Radiotherapy. Vincent GREGOIRE, M.D., Ph.D. Head and Neck Oncology Program, Radiation Oncology Dept. & Center for Molecular Imaging and Experimental Radiotherapy, Université Catholique de Louvain, St-Luc University Hospital, Brussels, Belgium Myths and facts in Oncology: the challenge of local therapies not cure (distal recurrence) not cure (local recurrence) 18% 37% 12% Radiotherapy Chemotherapy 5% 6% 22% Surgery + radiotherapy Surgery Myths and facts in Oncology: the challenge of local therapies in HNSCC Tumor Control Probability (TCP) Dose-response curve for neck nodes 3 cm not cure (distal recurrence) 25-35% 1-15% >>12% Chemotherapy % 22% Surgery >6% Tumor control (%) not cure (local recurrence) Radiotherapy Surgery + radiotherapy ± chemo/biological ± chemo/biological modifiers modifiers 2 45, T o t a l d o s e ( G y ) Bataini et al, 1982 Normal Tissue Control Probability (NTCP) Uncomplicated tumor control: Therapeutic Ratio Tumour control Human Monkey Effect Unacceptable normal tissue damage Uncomplicated tumour control Dose Baumann et al., Strahlenther Onkol 17: , 1994
2 Uncomplicated tumor control: Therapeutic Ratio Uncomplicated tumor control: Therapeutic Ratio Effect Tumour control Unacceptable normal tissue damage Effect Tumour control Unacceptable normal tissue damage Uncomplicated tumour control Uncomplicated tumour control Dose Dose Less effect per gray at low doses/# Fractionation sensitivity n N = Typical dose per fraction Gy for standard fractionation Gy for hyperfractionation Late effects Acute effects + tumor response Total dose (Gy) Withers et al, 1983 Hyperfractionation Decreased dose per fraction EORTC Hyperfractionation trial in oropharynx cancer Oropharyngeal Ca T2-3, N-1 Conventional fractionation Hyperfractionation ( pure, MFD) 2. Gy/ f, 1x/ d 6 weeks= 6 Gy 1. Gy/ f, 2x/ d 6 weeks= 6 Gy 8.5 Gy - 7 fx - 7 wks vs 7 Gy fx wks p =.2 p =.8 LOCAL CONTROL SURVIVAL Hyperfractionation ( dose escalated, MFD) 1.2 Gy/ f, 2x/ d 6 weeks= 72 Gy Hyperfractionation ( pure, SFD) 1.5 Gy/ f, 1x/ d 6 weeks= 6 Gy Years Years Horiot 1992
3 EGFR and repopulation during RT FaDu hscc EGF-Receptor Radiobiological and clinical issues in IMRT for HNSCC Influence of overall treatment time on HNSCC local control 12 TCD 5 (Gy) 6 T clon = 9.8d [;21] T clon = 3.4d [1.7;5] Day 22 [13;3] RDI pab Radiobiological hypoxia Tage nach 1. RT Petersen et al., IJRB 79: , 23 Withers et al, 1988 Accelerated fractionation (AF) Shortened overall treatment time, dose per week > 1 Gy IIIII IIIII IIIII IIIII IIIII IIIII IIII Gy/ 2. Gy/ 6.5w DAHANCA 6&7 - H&N SCC - stage II-IV (n=1476) IIIIII IIIIII IIIIII IIIIII IIIIII IIIIII Gy/ 2. Gy/ 5.5w CF 7Gy/ 2. Gy/ 7w CB 7Gy/ 2. Gy/ 5w AF/HF 54Gy/ 3x1.5Gy/ ti=6h/ 12d Expectations: Increased tumor control Increased early reactions Unchanged or decreased late damage (AF/HF and/or reduced total dose) Overgaard et al. Lancet, 23 H&N SCC: MACH-NC C225 anti EGFR Ab; A 431 tumours: c 1x 3x SD18Gy 18Gy + 1x 18Gy + 3x RT SD/1xC225 SD/3xC225 Milas et al. Clin Cancer Res 6: 71-78, 2 Nasu et al., IJROBP 51: , 21 Pignon, Lancet, 2
4 Efficacy EGF-R inhibitor and RxTh in HNSCC Phase III Study Design Erbitux + RT Stratify by Karnofsky score: 9-1 vs. 6-8 Regional Nodes: Negative vs. Positive Tumor stage: AJCC T1-3 vs. T4 RT fractionation: Concomitant boost vs. Once daily vs. Twice daily Arm 1 (RT) R A N D O M I Z E RT Radiation therapy Locoregional Control Erbitux + RT Arm 2 (RT+E) RT Radiation therapy + Cetuximab, weekly Bonner, 24 Log-rank p Image-Guided Radiation Therapy in HNSCC 1963 Overall Survival Bonner, 24 Image-Guided Radiation Therapy in HNSCC Intensity Modulated Radiation Therapy (IMRT)
5 Clinical outcome of IMRT in head and neck cancer GUH (3) Nasal cavity Paranasal sinus UCSF (2) Nasopharynx WU (4) All sites CUP U-M (1) Oral cavity Oro- hypopharynx Larynx (1) Eisbruch 1999, Dawson 2: University of Michigan (U-M) (2) Lee 22: University of California at San Francisco (UCSF) (3) Claus 22, Duthoy 23: Ghent University Hospital (GUH) (4) Chao 23: Washington University, St. Louis (WU) Cumulative incidence Cumulative incidence Head (3-5 FP) Deviation from the isocenter (mm) Neck (3-5 FP) Deviation from the isocenter (mm) Cumulative incidence Shoulder (4 & 5 FP) Deviation of the isocenter (mm) Image acquisition Dual detector spiral CT 2.7 mm collimation, pitch.7, reconstruction of mm Display matrix of 512 x 512 pixels Contrast enhancement (interstitial and blood vessel contrast) Conformal radiotherapy: 3D reconstruction Conformal radiotherapy: image display
6 Target volumes in Radiation Oncology: ICRU definition Conformal radiotherapy and IMRT in Head and Neck Tumors Gross Tumor Volume: GTV Clinical Target Volume: CTV Planning Target Volume: PTV Organs at Risk: OAR Planning Organ at Risk Volume: PRV ICRU report 62, 1999 Definition of the extend of the CTV in the neck Incidence of pathologic lymph node metastasis in oropharyngeal tumors State of the art Predictive pattern of lymph node involvement in HNSCC Selective neck treatment (irradiation or dissection) for selected N stage Clinically N neck (n=48) 2% 25% 19% 2% 8% Clinically N + neck (n=165) 15% 71% 42% 9% 27% From Candela, 199 Oropharyngeal Carcinoma Conformal radiotherapy and IMRT in Head and Neck Tumors Stage Ipsilateral neck Controlateral neck N-N1 (Ib 1 )-II-III-IV + RP for post. II-III-IV + RP for post. pharyngeal wall tumor pharyngeal wall tumor N2a-N2b Ib-II-III-IV-V +RP II-III-IV + RP for post. pharyngeal wall tumor N2c According to N stage on According to N stage on each side of the neck each side of the neck N3 I-II-III-IV-V +RP ± adjacent II-III-IV + RP for post. structures according to clinical pharyngeal wall tumor and radiological data 1 Ib only if extension to oral cavity Grégoire et al., 2 DAHANCA: EORTC: Radio/EDUCATION.htm RTOG:
7 CT-based delineation of lymph node levels in the neck: Brussels- Rotterdam consensus guidelines LIa LIb RP LII CT-based delineation of lymph node levels in the neck: Brussels- Rotterdam consensus guidelines Level Ia and Ib Level III symphysis menti / platysma hyoid bone / submandibular gland Lat. ant. belly of digastric m. (Ia) mandible / platysma (Ib) Med. ant. belly of digastric m. (Ib) Cra. geniohyoid m./mandible (Ia) mylohyoid m, submandibular gland (Ib) Cau. hyoid bone Ant. sternohyoid m./ sternocleidomastoid m. Post. sternocleidomastoid m. Lat. sternocleidomastoid m. Med. paraspinal m. int. carotid artery Cra. hyoid bone Cau. cricoid cartilage Ant. Post. LIII LV Mr H. D. (77 years): T3-N-M base of tongue (ICD-1: C1) Antique (7 fields) Rx 6 MV 4 Gy Elect 8 MeV 1 Gy Rx 6 MV 3 Gy Rx 6 MV 5 Gy Art nouveau (1 fields, 12 segments ) SRAO SLAO Post. Seg. 1 Art nouveau (11 fields, 12 segments ) Ant. Post. Seg. 2 RAO Rx 6 MV 5 Gy RPO LPO Ant. LPO Rx 6 MV 2 Gy LAO1 LAO2
8 Forward planning IMRT «human optimization» Inverse planning IMRT Spare cord Spare left parotid 15 segments 1 levels Cummulative % of MUs Segment # 1 6. Dose-volume constraints & weights for PTV and OARs optimization algorithms Penalty function Courtesy of C. Field Left parotid ADC Dose: 3 x 2. Gy Spinal cord Left parotid Right parotid PTVs Hypopharyngeal SCC T4-N-M Dose: 25 x 1.8 Gy bid Right parotid Spinal cord Inner ear PTV
9 Objective assessment Subjective assessment Maximum secretion (%) Bilateral irradiation Unilateral irradiation R=,77 SOMA scale (arbitrary units) Bilateral irradiation Unilateral irradiation R=, Mean parotid dose (Gy) Mean parotid dose (Gy) Oral cavity, oro- hypopharynx, larynx parotid-sparing 3D-CRT Nasopharynx 88 patients irradiated with parotid sparing saliva flow rates for 152 parotid glands dose / volume / function relationships parotid mean dose < 26 Gy is planning goal Lyman NTCP: n = 1, m =.18, TD5=28.4 Gy 67 patients treated April 1995-October 2 Stages I (n=8); II (n=12); III (n=22); IV (n=25) Non-keratinizing (n=34); undifferentiated (n=33) IMRT by compensators, MLC or MIMiC Conventional fields to treat the neck 12/58 patients developed recurrences: 1 in GTV region 2 in elective region (1 st echelon) Limits: local control in GTV area 4-year actuarial distant metastasis-free rate: 66% Limits: distant metastasis rate Lee et al. IJROBP 53: 12-22, 22 Paranasal sinus -Number of patients 44 -R surgery 44 - Male/female ratio 9/1 - Median age at diagnosis 6 years [3-76] - Subsite Ethmoid sinus 33 (75%) Maxillary sinus 6 (14%) Nasal cavity 5 (11%) Complications of postoperative radiation therapy for ethmoid sinus tumors period RT 2D 3D IMRT PTS Optic neuropathy 2 Dry eye syndrome 5 2 Limits: local control in T4(b) W. Duthoy, 23
10 Duration of treatment planning procedure 2D planning Forward planning Inverse planning (St-Luc) (Edmonton Cancer center) Volume delineation -.25h 2-3h 1-1.5h Planning.25h 2-8h 1-2h Individualized QC h.25h 1h Treatment (per session) 1-15 min 2-25 min 15 min Activity-Based Costing (ABC) in radiotherapy Type of treatment Cost (EURO) Palliative irradiation (1 fractions) 1,686 Breast irradiation (25 fractions) 2,71 H&N irradiation (35 fractions) 4,724 From Azoury, 2 CT MRI (T2) FDG-PET PRE-R/ (Week 2) WEEK 3 (Week 4) WEEK 5
Head & Neck Contouring
Head & Neck Contouring Presented by James Wheeler, MD Center for Cancer Care Goshen, IN 46526 September 12, 2014 Special Thanks to: Spencer Boulter, Director of Operations (AAMD) Adam Moore, RT(T), CMD
More informationVincent Grégoire, Radiation Oncologist, Brussels, Belgium Cai Grau, Radiation Oncologist, Aarhus, Denmark. Tunis March 2017
Guidelines for the delineation of the primary tumour Clinical Target Volumes (CTV) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity SCC (version 5.1) Vincent Grégoire, Radiation Oncologist,
More informationPractice teaching course on head and neck cancer management
28-29 October 2016 - Saint-Priest en Jarez, France Practice teaching course on head and neck cancer management IMPROVING THE PATIENT S LIFE LIFE THROUGH MEDICAL MEDICAL EDUCATION EDUCATION www.excemed.org
More informationChemo-radiation and targeted agents: biological basis
Chemoradiation and targeted agents: biological basis Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for highrisk cervical cancer. M. Morris et al, NEJM, 3:1137113,
More informationChapter 2. Level II lymph nodes and radiation-induced xerostomia
Chapter 2 Level II lymph nodes and radiation-induced xerostomia This chapter has been published as: E. Astreinidou, H. Dehnad, C.H. Terhaard, and C.P Raaijmakers. 2004. Level II lymph nodes and radiation-induced
More informationSimultaneous Integrated Boost or Sequential Boost in the Setting of Standard Dose or Dose De-escalation for HPV- Associated Oropharyngeal Cancer
Simultaneous Integrated Boost or Sequential Boost in the Setting of Standard Dose or Dose De-escalation for HPV- Associated Oropharyngeal Cancer Dawn Gintz, CMD, RTT Dosimetry Coordinator of Research and
More informationProtocol of Radiotherapy for Head and Neck Cancer
106 年 12 月修訂 Protocol of Radiotherapy for Head and Neck Cancer Indication of radiotherapy Indication of definitive radiotherapy with or without chemotherapy (1) Resectable, but medically unfit, or high
More informationUtilisation du PET-FDG pour la définition des volumes cibles en radiothérapie des tumeurs de la sphère cervico-maxillo-faciale: mythe et réalité
Utilisation du PET-FDG pour la définition des volumes cibles en radiothérapie des tumeurs de la sphère cervico-maxillo-faciale: mythe et réalité Vincent GREGOIRE, M.D., Ph.D. Head and Neck Oncology Program,
More informationLocally advanced head and neck cancer
Locally advanced head and neck cancer Radiation Oncology Perspective Petek Erpolat, MD Gazi University, Turkey Definition and Management of LAHNC Stage III or IV cancers generally include larger primary
More informationIMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia
IMRT - the physician s eye-view Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia The goals of cancer therapy Local control Survival Functional status Quality of life Causes
More informationReport of ICRU Committee on Volume and Dose Specification for Prescribing, Reporting and Recording in Conformal and IMRT A Progress Report
Report of ICRU Committee on Volume and Dose Specification for Prescribing, Reporting and Recording in Conformal and IMRT A Progress Report Paul M. DeLuca, Jr. 1, Ph.D., Vincent Gregoire 2, M.D., Ph.D.,
More informationUtilizzo delle tecniche VMAT nei trattamenti del testa collo Marta Scorsetti M.D.
Utilizzo delle tecniche VMAT nei trattamenti del testa collo Marta Scorsetti M.D. Radiotherapy and Radiosurgery Dpt. Istituto Clinico Humanitas, Milan, Italy. Higher doses to the tumor Better sparing of
More informationRADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS. Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1.
RADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1. 550 000 NEW PATIENTS/YEAR WITH HEAD AND NECK CANCER ALL
More information4D-IMRT. The facts, the needs and the solutions. Adaptive radiotherapy in the head and. neck: what is the clinical significance?
Adaptive radiotherapy in the head and neck: what is the clinical significance? Vincent GREGOIRE, MD, PhD, Hon. FRCR Radiation Oncology Dept. Head and Neck Oncology Program & Center for Molecular Imaging
More informationCURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER
CURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER Jean-Pascal Machiels Department of medical oncology Institut I Roi Albert II Cliniques universitaires Saint-Luc Université catholique de Louvain, Brussels,
More informationEvaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer
1 Charles Poole April Case Study April 30, 2012 Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer Abstract: Introduction: This study
More informationFrom GTV to CTV: A Critical Step Towards Cure. Kenneth Hu, MD Associate Professor New York University Langone Medical Center June 21, 2017
From GTV to CTV: A Critical Step Towards Cure Kenneth Hu, MD Associate Professor New York University Langone Medical Center June 21, 2017 Head and Neck Cancer Model for Understanding CTV Expansion Radiation
More informationCANCERS of OROPHARYNX and HYPOPHARYNX. STAGING and TREATMENT
1 CANCERS of OROPHARYNX and HYPOPHARYNX STAGING and TREATMENT 2 1. Staging 2. General Principles of Treatment 3. Site Specific Treatment Guidelines 4. Selected Abstracts from Relevant Studies 3 1. Staging
More informationProtons for Head and Neck Cancer. William M Mendenhall, M.D.
Protons for Head and Neck Cancer William M Mendenhall, M.D. Protons for Head and Neck Cancer Potential Advantages: Reduce late complications via more conformal dose distributions Likely to be the major
More informationQuality Variation and Clinical Impact in Head and Neck IMRT
Quality Variation and Clinical Impact in Head and Neck IMRT 6 th IMRT Symposium, New York Sep. 20, 2010 K.S. Clifford Chao, MD Chairman, Combined Radiation Oncology, New York Presbyterian Hospital Chairman,
More informationMANAGEMENT OF CA HYPOPHARYNX
MANAGEMENT OF CA HYPOPHARYNX GENERAL TREATMENT RECOMMENDATIONS BASED ON HYPOPHARYNX TUMOR STAGE For patients presenting with early-stage definitive radiotherapy alone or voice-preserving surgery are viable
More informationState of the art for radiotherapy of SCCHN
State of the art for radiotherapy of SCCHN Less side effects Cured More organ & function preservation Head & neck cancer = 42 000 new cases / year in Europe Not cured Local failure Distant failure More
More informationPre- Versus Post-operative Radiotherapy
Postoperative Radiation and Chemoradiation: Indications and Optimization of Practice Dislosures Clinical trial support from Genentech Inc. Sue S. Yom, MD, PhD Associate Professor UCSF Radiation Oncology
More informationMick Spillane. Medical. Intensity-Modulated Radiotherapy for Sinonasal Tumors
Mick Spillane Medical Formatted: Left Intensity-Modulated Radiotherapy for Sinonasal Tumors F Division of Radiotherapy, Department of Oncology (I. M., L. V., W. D. N.), and Division of Head and Neck Surgery,
More informationThis house believes that the use of Functional Imaging for treatment planning of head and neck tumors needs to be carefully considered.
This house believes that the use of Functional Imaging for treatment planning of head and neck tumors needs to be carefully considered. IMRT for Head and Neck Tumors Vincent GREGOIRE, M.D., Ph.D., Hon.
More informationIntensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) Policy Number: Original Effective Date: MM.05.006 03/09/2004 Line(s) of Business: Current Effective Date: HMO; PPO 06/24/2011 Section: Radiology Place(s) of
More informationHead & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i
Greater Manchester, Lancashire & South Cumbria Strategic Clinical Network & Senate Head & Neck Clinical Sub Group Network Agreed Imaging Guidelines for UAT and Thyroid Cancer Measure Nos: 11-1C-105i &
More informationREVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria
REVISITING ICRU VOLUME DEFINITIONS Eduardo Rosenblatt Vienna, Austria Objective: To introduce target volumes and organ at risk concepts as defined by ICRU. 3D-CRT is the standard There was a need for a
More informationCitation Key for more information see:
Citation Key for more information see: http://open.umich.edu/wiki/citationpolicy Use + Share + Adapt { Content the copyright holder, author, or law permits you to use, share and adapt. } Public Domain
More informationDefining Target Volumes and Organs at Risk: a common language
Defining Target Volumes and Organs at Risk: a common language Eduardo Rosenblatt Section Head Applied Radiation Biology and Radiotherapy (ARBR) Section Division of Human Health IAEA Objective: To introduce
More informationIntensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) Policy Number: Original Effective Date: MM.05.006 03/09/2004 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 05/01/2017 Section: Radiology
More informationThe objective of this lecture is to integrate our knowledge of the differences between 2D and 3D planning and apply the same to various clinical
The objective of this lecture is to integrate our knowledge of the differences between 2D and 3D planning and apply the same to various clinical sites. The final aim will be to be able to make out these
More informationDe-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist
De-Escalate Trial for the Head and neck NSSG Dr Eleanor Aynsley Consultant Clinical Oncologist 3 HPV+ H&N A distinct disease entity Leemans et al., Nature Reviews, 2011 4 Good news Improved response to
More informationChapters from Clinical Oncology
Chapters from Clinical Oncology Lecture notes University of Szeged Faculty of Medicine Department of Oncotherapy 2012. 1 RADIOTHERAPY Technical aspects Dr. Elemér Szil Introduction There are three possibilities
More informationSAMO MASTERCLASS HEAD & NECK CANCER. Nicolas Mach, PD Geneva University Hospital
SAMO MASTERCLASS HEAD & NECK CANCER Nicolas Mach, PD Geneva University Hospital Epidemiology Prevention Best treatment for localized disease Best treatment for relapsed or metastatic disease Introduction
More informationDiagnosis and what happens after referral
Diagnosis and what happens after referral Dr Kate Newbold Consultant in Clinical Oncology The Royal Marsden Women's cancers Breast cancer introduction 1 Treatment Modalities Early stage disease -larynx
More information67 F, 40 PY Smoker, Past heavy alcohol consumer, h/o COPD, Congestive heart failure. Presentation: Lump left upper neck x 1 year, non-tender, no
67 F, 40 PY Smoker, Past heavy alcohol consumer, h/o COPD, Congestive heart failure. Presentation: Lump left upper neck x 1 year, non-tender, no overlying skin changes, gradually increasing in size. Recent
More informationHelical tomotherapy for head and neck squamous cell carcinoma: Dosimetric comparison with linear accelerator-based step-and-shoot IMRT
Original Article Free full text available from www.cancerjournal.net Helical tomotherapy for head and neck squamous cell carcinoma: Dosimetric comparison with linear accelerator-based step-and-shoot IMRT
More informationNCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) BONE (Version , 03/28/18)
BONE (Version 2.2018, 03/28/18) NCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) Radiation Therapy Specialized techniques such as intensity-modulated RT (IMRT); particle beam RT with protons, carbon ions,
More informationHPV INDUCED OROPHARYNGEAL CARCINOMA radiation-oncologist point of view. Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium
HPV INDUCED OROPHARYNGEAL CARCINOMA radiation-oncologist point of view Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium DISCLOSURE OF INTEREST Nothing to declare HEAD AND NECK CANCER -HPV
More informationTHE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS
THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS ICTP SCHOOL ON MEDICAL PHYSICS FOR RADIATION THERAPY DOSIMETRY AND TREATMENT PLANNING FOR BASIC AND ADVANCED APPLICATIONS March
More informationOral cavity cancer Post-operative treatment
Oral cavity cancer Post-operative treatment Dr. Christos CHRISTOPOULOS Radiation Oncologist Centre Hospitalier Universitaire (C.H.U.) de Limoges, France Important issues RT -techniques Patient selection
More informationEfficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO
Investigations and research Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO M. Kunze-Busch P. van Kollenburg Department of Radiation Oncology, Radboud University Nijmegen Medical
More informationA VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM *
Romanian Reports in Physics, Vol. 66, No. 2, P. 401 410, 2014 A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM * M. D. SUDITU 1,2, D. ADAM 1,2, R. POPA 1,2, V. CIOCALTEI
More informationQ&A. Fabulous Prizes. Collecting Cancer Data: Pharynx 12/6/12. NAACCR Webinar Series Collecting Cancer Data Pharynx
Collecting Cancer Data Pharynx NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationManagement of unknown primary with neck node metastasis: Current evidence
Management of unknown primary with neck node metastasis: Current evidence Dr. Pooja Nandwani Patel Associate Professor Dept. of Radiation Oncology GCRI, Ahmedabad Introduction- Approach to Topic What is
More informationIMRT IN HEAD NECK CANCER
IMRT IN HEAD NECK CANCER THE SEARCH FOR CONFORMALITY CONVENTIONAL RT Simple field arrangements Uniformly radiate both the target and the surrounding normal tissues. Includes the use of rectangular blocks
More informationIntensity-modulated radiation therapy for nasopharyngeal carcinoma: a review
J Radiat Oncol (2012) 1:129 146 DOI 10.1007/s13566-012-0020-4 REVIEW Intensity-modulated radiation therapy for nasopharyngeal carcinoma: a review Tony J. C. Wang & Nadeem Riaz & Simon K. Cheng & Jiade
More informationHALF. Who gets radiotherapy? Who gets radiotherapy? Half of all cancer patients get radiotherapy. By 1899 X rays were being used for cancer therapy
The Physical and Biological Basis of By 1899 X rays were being used for cancer therapy David J. Brenner, PhD, DSc Center for Radiological Research Department of Radiation Oncology Columbia University Medical
More informationOral Cavity Cancer Combined modality therapy
Oral Cavity Cancer Combined modality therapy Dr. Christos CHRISTOPOULOS Radiation Oncologist Head and Neck Cancers Centre Hospitalier Universitaire (C.H.U.) de Limoges, France Disclosure slide I have no
More informationES-SCLC Joint Case Conference. Anthony Paravati Adam Yock
ES-SCLC Joint Case Conference Anthony Paravati Adam Yock Case 57 yo woman with 35 pack year smoking history presented with persistent cough and rash Chest x-ray showed a large left upper lobe/left hilar
More informationState of the Art Radiotherapy for Pediatric Tumors. Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center
State of the Art Radiotherapy for Pediatric Tumors Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center Introduction Progress and success in pediatric oncology Examples of low-tech and high-tech
More informationIntensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) Policy Number: Original Effective Date: MM.05.006 03/09/2004 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 03/01/2015 Section: Radiology
More informationDosimetric Comparison of Intensity-Modulated Radiotherapy versus 3D Conformal Radiotherapy in Patients with Head and Neck Cancer
Dosimetric Comparison of Intensity-Modulated Radiotherapy versus 3D Conformal Radiotherapy in Patients with Head and Neck Cancer 1- Doaa M. AL Zayat. Ph.D of medical physics, Ayadi-Al Mostakbl Oncology
More information肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部
肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部 Outline Current status of radiation oncology in lung cancer Focused on stage III non-small cell lung cancer Radiation
More informationHead and Neck Service
Head and Neck Service University of California, San Francisco, Department of Radiation Oncology Residency Training Program Head and Neck and Thoracic Service Educational Objectives for PGY-5 Residents
More informationTOMOTERAPIA in Italia: Esperienze a confronto
TOMOTERAPIA in Italia: Esperienze a confronto BARD 20 novembre 2010 L esperienza di Reggio Emilia Testa collo Alessandro Muraglia Reasons for the use of tomotherapy: - Complex tumor geometry and proximity
More informationUpdate on Limited Small Cell Lung Cancer. Laurie E Gaspar MD, MBA Prof/Chair Radiation Oncology University of Colorado Denver
Update on Limited Small Cell Lung Cancer Laurie E Gaspar MD, MBA Prof/Chair Radiation Oncology University of Colorado Denver Objectives - Limited Radiation Dose Radiation Timing Radiation Volume PCI Neurotoxicity
More informationLong-term parotid gland function after radiotherapy
Parotid gland sparing radiotherapy, P.M. Braam Chapter 2 Long-term parotid gland function after radiotherapy Pètra M. Braam 1, Judith M. Roesink 1, Marinus A. Moerland 1, Cornelis P.J. Raaijmakers 1, Maria
More informationAJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY-
TX: primary tumor cannot be assessed T0: no evidence of primary tumor Tis: carcinoma in situ. T1: tumor is 2 cm or smaller AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY- T2:
More informationTreatment Planning & IGRT Credentialing for NRG SBRT Trials
Treatment Planning & IGRT Credentialing for NRG SBRT Trials Hania Al Hallaq, Ph.D. Department of Radiation & Cellular Oncology The University of Chicago Learning Objectives Explain rationale behind credentialing
More informationCarcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY
Carcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY SEARCHING FOR THE PRIMARY? P r o f J P P r e t o r i u s H e a d : C l i n i c a l U n i t C r i t i c a l C a r e U n i v e r s i t y O f
More informationBEPERKEN VAN DE BESTRALING TOT EENZIJDIGE HALS MIDDELS SPECT-CT
BEPERKEN VAN DE BESTRALING TOT EENZIJDIGE HALS MIDDELS SPECT-CT ONCOLOGIE IN PERSPECTIEF: (OVER)LEVEN AL-MAMGANI, MD, PHD RADIOTHERAPEUT-ONCOLOOG WAAROM BILATERAAL WAAROM BILATERAAL BACKGROUND BILATERALE
More informationAdjuvant Therapy in Locally Advanced Head and Neck Cancer. Ezra EW Cohen University of Chicago. Financial Support
Adjuvant Therapy in Locally Advanced Head and Neck Cancer Ezra EW Cohen University of Chicago Financial Support This program is made possible by an educational grant from Eli Lilly Oncology, who had no
More informationInternational Multispecialty Journal of Health (IMJH) ISSN: [ ] [Vol-3, Issue-9, September- 2017]
Dosimetric evaluation of carcinoma nasopharynx using Volumetric Modulated Arc Therapy (VMAT): An institutional experience from Western India Dr. Upendra Nandwana 1, Dr. Shuchita Pathak 2, Dr. TP Soni 3,
More informationLYMPHATIC DRAINAGE IN THE HEAD & NECK
LYMPHATIC DRAINAGE IN THE HEAD & NECK Like other parts of the body, the head and neck contains lymph nodes (commonly called glands). Which form part of the overall Lymphatic Drainage system of the body.
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationRT +/- Surgery. Concurrent ChemoRT +/- Surgery
Molecular targeted approaches to head and neck cancer Lillian L. Siu Department of Medical Oncology & Hematology Princess Margaret Hospital, University of Toronto Locally Advanced HNSCC Locally Advanced
More informationHead & Neck Cancer: When to Irradiate
Head & Neck Cancer: When to Irradiate ESO-ESMO Latin-America 2018 Talented students colleagues 1 > 15 different diseases for RT strategies NC NP OC OP H L 2 HPV Prognostic Marker >2010 Trial Cases Marker
More informationCase Scenario #1 Larynx
Case Scenario #1 Larynx 56 year old white female who presented with a 2 month history of hoarseness treated with antibiotics, but with no improvement. In the last 3 weeks, she has had a 15 lb weight loss,
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationYuzuru Niibe 1, Katsuyuki Karasawa 1, Toshio Mitsuhashi 2 and Yoshiaki Tanaka 3 INTRODUCTION. Jpn J Clin Oncol 2003;33(9)
Jpn J Clin Oncol 2003;33(9)450 455 Hyperfractionated Radiation Therapy for Hypopharyngeal Carcinoma Compared with Conventional Radiation Therapy: Local Control, Laryngeal Preservation and Overall Survival
More informationHead and Neck Reirradiation: Perils and Practice
Head and Neck Reirradiation: Perils and Practice David J. Sher, MD, MPH Department of Radiation Oncology Dana-Farber Cancer Institute/ Brigham and Women s Hospital Conflicts of Interest No conflicts of
More informationCorporate Medical Policy
Corporate Medical Policy Intensity Modulated Radiation Therapy (IMRT) of Head and Neck File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_head_and_neck
More informationAJCC Cancer Staging 8 th edition. Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx
AJCC Cancer Staging 8 th edition Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx AJCC 7 th edition Lip and Oral cavity Pharynx Larynx KEY CHANGES Skin of head and neck (Vermilion of the lip)
More informationTreatment Planning for Breast Cancer: Contouring Targets. Julia White MD Professor
Treatment Planning for Breast Cancer: Contouring Targets Julia White MD Professor Outline 1. RTOG Breast Cancer Atlas 2. Target development on Clinical Trials Whole Breast Irradiation 2-D Radiotherapy
More informationCALGB Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
CALGB 30610 Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer Jeffrey A. Bogart Department of Radiation Oncology Upstate Medical University Syracuse, NY Small Cell Lung Cancer Estimated 33,000
More informationDose escalation for NSCLC using conformal RT: 3D and IMRT. Hasan Murshed
Dose escalation for NSCLC using conformal RT: 3D and IMRT. Hasan Murshed Take home message Preliminary data shows CRT technique in NSCLC allows dose escalation to an unprecedented level maintaining cancer
More informationSequencing Chemo with Radiation therapy Locally Advanced Head and Neck Cancer. Dr P Vijay Anand Reddy Director Apollo Cancer Hospital
Sequencing Chemo with Radiation therapy Locally Advanced Head and Neck Cancer Dr P Vijay Anand Reddy Director Apollo Cancer Hospital H&N Ca - Disease Burden 15-20% of all cancers in India, 8% worldwide
More informationDOES RADIOTHERAPY TECHNIQUE / DOSE / FRACTIONATION REALLY MATTER? YES
DOES RADIOTHERAPY TECHNIQUE / DOSE / FRACTIONATION REALLY MATTER? YES Marco Krengli Radiotherapy, Department of Translational Medicine, University of Piemonte Orientale A. Avogadro THE STANDARD OF CARE
More informationDose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83
Special report Dose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83 Rapid development in imaging techniques, including functional imaging,
More informationTREATMENT TIME & TOBACCO: TWIN TERRORS Of H&N Therapy
TREATMENT TIME & TOBACCO: TWIN TERRORS Of H&N Therapy Anurag K. Singh, MD Professor of Medicine University at Buffalo School of Medicine Professor of Oncology Director of Radiation Research Roswell Park
More informationHPV POSITIVE OROPHARYNGEAL CARCINOMA the radiation oncologist point of view. Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium
HPV POSITIVE OROPHARYNGEAL CARCINOMA the radiation oncologist point of view Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium HEAD AND NECK CANCER -HPV Change in incidence: HEAD AND NECK
More informationPage 1. Helical (Spiral) Tomotherapy. UW Helical Tomotherapy Unit. Helical (Spiral) Tomotherapy. MVCT of an Anesthetized Dog with a Sinus Tumor
Helical (Spiral) Tomotherapy Novel Clinical Applications of IMRT Linac Ring Gantry CT Detector X-Ray Fan Beam Binary Multileaf Collimator Binary MLC Leaves James S Welsh, MS, MD Department of Human Oncology
More informationREIRRADIATION OF HEAD & NECK TARGETS
REIRRADIATION OF HEAD & NECK TARGETS WORKSHOP-Current challenges of patient re-irradiation 6-7 september 2018, Stockholm, Sweden Claes Mercke Karolinska Institute and Karolinska University Hospital STOCKHOLM
More informationIntensity Modulated Radiation Therapy (IMRT): Cancer of the Head and Neck or Thyroid. Original Policy Date
MP 8.01.26 Intensity Modulated Radiation Therapy (IMRT): Cancer of the Head and Neck or Thyroid Medical Policy Section Therapy Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Reviewed
More informationAdvances in external beam radiotherapy
International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada
More informationThe Integration and Impact of Modern Radiotherapy Techniques in Clinical Practice. Kian Ang
The Integration and Impact of Modern Radiotherapy Techniques in Clinical Practice Kian Ang Funding: P01-CA06294, R01-CA84415, GF Fletcher Chair, Imclone (phase III trial) From Bench to Bedside Head and
More informationA Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer
A Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer Tony Kin Ming Lam Radiation Planner Dr Patricia Lindsay, Radiation Physicist Dr John Kim, Radiation Oncologist Dr Kim Ann Ung,
More informationProtocol of Radiotherapy for Breast Cancer
107 年 12 月修訂 Protocol of Radiotherapy for Breast Cancer Indication of radiotherapy Indications for Post-Mastectomy Radiotherapy (1) Axillary lymph node 4 positive (2) Axillary lymph node 1-3 positive:
More informationTOPICS. Primary Radiation Therapy. Targeted Therapy in Oncology. Principles of Radiation Therapy. Principles of Radiation Therapy
Peter B. Schiff, M.D., Ph.D. Department of Radiation Oncology Columbia University College of Physicians & Surgeons May 4, 2007 Targeted Therapy in Oncology Surgical Oncology Minimal invasive techniques
More informationMarco Trovò CRO-Aviano
From pre-clinical research to clinical practice in radiation therapy: new predictive factors and biological markers to predict normal tissue toxicity after radiation therapy of the lung. Marco Trovò CRO-Aviano
More informationClinical Implications Of Dose Summation And Adaptation
Clinical Implications Of Dose Summation And Adaptation Patrick Kupelian, M.D. Professor and Vice Chair University of California Los Angeles Department of Radiation Oncology pkupelian@mednet.ucla.edu August
More informationNew Technologies for the Radiotherapy of Prostate Cancer
Prostate Cancer Meyer JL (ed): IMRT, IGRT, SBRT Advances in the Treatment Planning and Delivery of Radiotherapy. Front Radiat Ther Oncol. Basel, Karger, 27, vol. 4, pp 315 337 New Technologies for the
More informationCase Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 1 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of
More informationHead and Neck Treatment Planning: A Comparative Review of Static Field IMRT RapidArc TomoTherapy HD. Barbara Agrimson, BS RT(T)(R), CMD
Head and Neck Treatment Planning: A Comparative Review of Static Field IMRT RapidArc TomoTherapy HD Barbara Agrimson, BS RT(T)(R), CMD Disclaimer This presentation will mention equipment by trade name.
More informationTherapy of Locally Advanced Head and Neck Cancer: State of the Art
Therapy of Locally Advanced Head and Neck Cancer: State of the Art Barbara Burtness, MD Chief, Head and Neck ncology Medical ncology Co-Leader Senior Member Fox Chase Cancer Center Philadelphia, PA Therapy
More informationOutline. Contour quality control. Dosimetric impact of contouring errors and variability in Intensity Modulated Radiation Therapy (IMRT)
Dosimetric impact of contouring errors and variability in Intensity Modulated Radiation Therapy (IMRT) James Kavanaugh, MS DABR Department of Radiation Oncology Division of Medical Physics Outline Importance
More informationThe Physics of Oesophageal Cancer Radiotherapy
The Physics of Oesophageal Cancer Radiotherapy Dr. Philip Wai Radiotherapy Physics Royal Marsden Hospital 1 Contents Brief clinical introduction Imaging and Target definition Dose prescription & patient
More information